Relafen 750, a advanced formulation of naproxen, represents a intriguing example from the biochemical pharmacy perspective. This mechanism of action, primarily involving suppression of cyclooxygenase enzymes and COX-1 and COX-2 – leads to the lowering in prostaglandin production. Within the biochemical context, the drug's efficacy is closely asso